Displaying drugs 13801 - 13825 of 14842 in total
(R)-minalrestat
Experimental
5-Bromoindirubin
Experimental
2-heptyl-4-hydroxyquinoline N-oxide
Experimental
9-(3-IODOBENZYLAMINO)-1,2,3,4-TETRAHYDROACRIDINE
Experimental
2-(2-METHYLPHENYL)-1H-INDOLE-5-CARBOXIMIDAMIDE
Experimental
HYDROXY[3-(6-METHYLPYRIDIN-2-YL)PROPYL]FORMAMIDE
Experimental
Thiacloprid
Experimental
Indoleacetamide
Experimental
9-ACETYL-2,3,4,9-TETRAHYDRO-1H-CARBAZOL-1-ONE
Experimental
Indalpine
Indalpine was one of the first selective serotonin reuptake inhibitors to reach the American market. It was initially marketed by Pharmuka. However, after the emergence of widespread concern regarding adverse effects caused by SSRIs, and reported hematological effects caused by Indalpine, it was abruptly withdrawn from the US market.
Investigational
Withdrawn
Matched Description: … However, after the emergence of widespread concern regarding adverse effects caused by SSRIs, and reported …
Piromelatine
Piromelatine has been used in trials studying the treatment of Alzheimer's Disease.
Investigational
Bizelesin
Bizelesin has been used in trials studying the treatment of Unspecified Adult Solid Tumor, Protocol Specific.
Investigational
Displaying drugs 13801 - 13825 of 14842 in total